Table of Contents
1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of
the Markets Covered in the Report 12
3.1 Drug delivery devices 12
3.2
Inhalation Systems 12
3.2.1 Metered Dose Inhaler 12
3.2.2 Dry powder
inhaler 12
3.3 Infusion Systems 12
3.3.1 Infusion pumps 12
3.3.2
Syringe pumps 12
3.3.3 Disposable Infusion sets 13
4 Healthcare Sector
Review 14
4.1 Healthcare Sector Review 14
4.2 Healthcare Expenditure
14
5 Regulation System 15
5.1 Regulatory System 15
5.2
Registration 15
5.3 Standards 16
5.4 Customs Duties 16
5.5
Labeling 16
6 Pricing and Reimbursement 17
7 Distribution Structure
18
8 Drug Delivery Devices In Israel 19
8.1 Drug Delivery Devices
Cross Country Comparison (2000-2012) 19
8.2 Drug Delivery Devices, Israel,
Overall Revenues ($ mn), 2000-2012 20
8.3 Drug Delivery Devices, Israel,
Category Volume (Units), 2000-2012 24
8.4 Drug Delivery Devices, Israel,
Company Share (2006-2007) 27
9 Infusion Systems In Israel 28
9.1
Infusion Systems Overall Revenue (2000-2012) 28
9.2 Infusion Systems
Overall Volume (2000-2012) 30
9.3 Infusion Systems Average Price
(2000-2012) 31
9.4 Infusion Systems Distribution Share (2006-2007) 32
9.5 Infusion Systems, Israel, Company Share (2006-2007) 33
10 Inhalation
Systems In Israel 34
10.1 Inhalation Systems Overall Revenue (2000-2012)
34
10.2 Inhalation Systems Overall Volume (2000-2012) 36
10.3
Inhalation Systems Average Price (2000-2012) 38
10.4 Inhalation Systems
Distribution Share (2006-2007) 38
10.5 Inhalation Systems, Israel, Company
Share (2006-2007) 39
11 AstraZeneca PLC Company Profile 40
11.1
Company Overview 40
12 3M Company Company Profile 41
12.1 Company
Overview 41
12.2 Value Chain Analysis 42
12.2.1 Manufacturing 42
12.2.1.1 In House Manufacturing 42
12.2.2 Product Development 42
12.2.2.1 Regulatory Approvals 42
12.2.2.2 Clinical Trials 42
12.2.2.3
Research and Development 43
12.2.3 Sales and Marketing 43
12.2.3.1
Partnerships and Alliances 43
12.2.3.2 Licensing Agreements 43
12.2.3.3 E-distribution 43
13 GlaxoSmithKline plc Company Profile 44
13.1 Company Overview 44
14 Novartis Medical Nutrition Company Profile
45
14.1 Company Overview 45
15 Cardinal Health, Inc. Company Profile
46
15.1 Company Overview 46
15.2 Value Chain Analysis 47
15.2.1
Manufacturing 47
15.2.1.1 In House Manufacturing 47
15.2.1.2
Outsourcing 48
15.2.2 Product Development 48
15.2.2.1 Regulatory
Approvals 48
15.2.2.2 Research and Development 48
15.2.3 Sales and
Marketing 48
15.2.3.1 Partnerships and Alliances 48
15.2.3.2 Licensing
Agreements 48
16 Baxter International Inc. Company Profile 49
16.1
Company Overview 49
16.2 Value Chain Analysis 50
16.2.1 Manufacturing
50
16.2.1.1 In House Manufacturing 50
16.2.2 Product Development
50
16.2.2.1 Regulatory Approvals 50
16.2.2.2 Clinical Trials 51
16.2.2.3 Research and Development 51
16.2.3 Sales and Marketing 51
16.2.3.1 Partnerships and Alliances 51
16.2.3.2 Licensing Agreements
51
16.2.3.3 E-distribution 52
17 E-Pill Pharma Ltd. Company Profile
53
17.1 Company Overview 53
17.2 E-Pill Pharma Ltd. Pipeline Products
53
17.2.1 E-Pill Pharma Ltd. Pipeline Products By Equipment Type 53
17.2.2 E-Pill Pharma Ltd. Pipeline Products By Development Stage 53
17.2.3
E-Pill Pharma Ltd. Pipeline Products By Therapy Area 53
18 Maya Biotech
Ltd. Company Profile 54
18.1 Company Overview 54
18.2 Maya Biotech
Ltd. Pipeline Products 54
18.2.1 Maya Biotech Ltd. Pipeline Products By
Equipment Type 54
18.2.2 Maya Biotech Ltd. Pipeline Products By
Development Stage 54
18.2.3 Maya Biotech Ltd. Pipeline Products By Therapy
Area 54
19 Meytav Technological Incubator Company Profile 55
19.1
Company Overview 55
20 NanoPass Technologies Ltd. Company Profile 56
20.1 Company Overview 56
21 NeuroDerm Ltd. Company Profile 57
21.1
NeuroDerm Ltd. Pipeline Products 57
21.1.1 NeuroDerm Ltd. Pipeline
Products By Equipment Type 57
21.1.2 NeuroDerm Ltd. Pipeline Products By
Development Stage 57
21.1.3 NeuroDerm Ltd. Pipeline Products By Therapy
Area 57
21.1.4 NeuroDerm Ltd. Pipeline Products By Clinical Trials 57
22 OcuPharma Ltd. Company Profile 58
22.1 OcuPharma Ltd. Pipeline Products
58
22.1.1 OcuPharma Ltd. Pipeline Products By Equipment Type 58
22.1.2
OcuPharma Ltd. Pipeline Products By Development Stage 58
22.1.3 OcuPharma
Ltd. Pipeline Products By Therapy Area 58
23 ORADEL MEDICAL LTD. Company
Profile 59
23.1 ORADEL MEDICAL LTD. Pipeline Products 59
23.1.1 ORADEL
MEDICAL LTD. Pipeline Products By Equipment Type 59
23.1.2 ORADEL MEDICAL
LTD. Pipeline Products By Development Stage 59
23.1.3 ORADEL MEDICAL LTD.
Pipeline Products By Therapy Area 59
24 RescueDose L.T.D. Company Profile
60
24.1 RescueDose L.T.D. Pipeline Products 60
24.1.1 RescueDose
L.T.D. Pipeline Products By Equipment Type 60
24.1.2 RescueDose L.T.D.
Pipeline Products By Development Stage 60
24.1.3 RescueDose L.T.D.
Pipeline Products By Therapy Area 60
25 SONENCO LTD. Company Profile
61
25.1 SONENCO LTD. Pipeline Products 61
25.1.1 SONENCO LTD. Pipeline
Products By Equipment Type 61
25.1.2 SONENCO LTD. Pipeline Products By
Equipment Type 61
25.1.3 SONENCO LTD. Pipeline Products By Therapy Area
61
26 SteadyMed Ltd. Company Profile 62
26.1 Company Overview 62
26.2 SteadyMed Ltd. Pipeline Products 62
26.2.1 SteadyMed Ltd. Pipeline
Products By Equipment Type 62
26.2.2 SteadyMed Ltd. Pipeline Products By
Development Stage 62
26.2.3 SteadyMed Ltd. Pipeline Products By Therapy
Area 62
26.2.4 SteadyMed Ltd. Pipeline Products By News Summary 62
27
Unique Flow Ltd. Company Profile 63
27.1 Unique Flow Ltd. Pipeline
Products 63
27.1.1 Unique Flow Ltd. Pipeline Products By Equipment Type
63
27.1.2 Unique Flow Ltd. Pipeline Products By Development Stage 63
27.1.3 Unique Flow Ltd. Pipeline Products By Therapy Area 63
28 APPENDIX
64
28.1 Global Markets Direct Research Methodology 64
28.2 Coverage
65
28.3 Secondary Research 65
28.4 Primary Research 66
28.5 Models
66
28.6 Forecasts 67
28.7 Expert Panels 67
28.8 Currency
Conversion 68
28.9 Contact Us 69
28.10 Disclaimer 69
1.1 List
of Tables
Table 1: Drug Delivery Devices Cross Country Comparison
(2000-2012) 19
Table 2: Drug Delivery Devices, Israel, Overall
Revenues ($ mn), 2000-2012 20
Table 3: Drug Delivery Devices, Israel,
Portfolio Analysis, 2000-2012 21
Table 4: Drug Delivery Devices,
Israel, Overall Revenues ($ mn), Historic, 2000-2007 22
Table 5: Drug
Delivery Devices, Israel, Overall Revenues ($ mn), Forecast, 2007-2012 23
Table 6: Drug Delivery Devices, Israel, Category Volume (Units),
2000-2012 24
Table 7: Drug Delivery Devices, Israel, Category Volume
(Units), Historic, 2000-2007 25
Table 8: Drug Delivery Devices,
Israel, Category Volume (Units), Forecast, 2007-2012 26
Table 9: Drug
Delivery Devices, Israel, Company Share by Revenue ($ mn), 2006-2007 27
Table 10: Infusion Systems, Israel, Revenue ($ mn) by Segment, Historic,
2000-2007 28
Table 11: Infusion Systems, Israel, Revenue ($ mn) by
Segment, Forecast, 2007-2012 29
Table 12: Infusion Systems, Israel,
Overall Volume (Units), Historic, 2000-2007 30
Table 13: Infusion
Systems, Israel, Overall Volume (Units), Forecast, 2007-2012 30
Table 14:
Infusion Systems, Israel, Average Price ($), Historic, 2000-2007 31
Table 15: Infusion Systems, Israel, Average Price ($), Forecast,
2007-2012 31
Table 16: Infusion Systems, Israel, Distribution Share
by Revenue ($mn), 2006-2007 32
Table 17: Infusion Systems, Israel,
Company Share by Revenue ($ mn), 2006-2007 33
Table 18: Inhalation
Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007 34
Table
19: Inhalation Systems, Israel, Revenue ($ mn) by Segment, Forecast,
2007-2012 35
Table 20: Inhalation Systems, Israel, Overall Volume
(Units), Historic, 2000-2007 36
Table 21: Inhalation Systems, Israel,
Overall Volume (Units), Forecast, 2007-2012 37
Table 22: Inhalation
Systems, Israel, Average Price ($), Historic, 2000-2007 38
Table 23:
Inhalation Systems, Israel, Average Price ($), Forecast, 2007-2012 38
Table 24: Inhalation Systems, Israel, Distribution Share by Revenue
($mn), 2006-2007 38
Table 25: Inhalation Systems, Israel, Company
Share by Revenue ($ mn), 2006-2007 39
Table 26: E-Pill Pharma Ltd.
Pipeline Products by Equipment Type 53
Table 27: E-Pill Pharma Ltd.
Pipeline Products by Development Stage 53
Table 28: E-Pill Pharma
Ltd. Pipeline Products By Therapy Area 53
Table 29: Maya Biotech Ltd.
Pipeline Products by Equipment Type 54
Table 30: Maya Biotech Ltd.
Pipeline Products by Development Stage 54
Table 31: Maya Biotech Ltd.
Pipeline Products By Therapy Area 54
Table 32: NeuroDerm Ltd.
Pipeline Products by Equipment Type 57
Table 33: NeuroDerm Ltd.
Pipeline Products by Development Stage 57
Table 34: NeuroDerm Ltd.
Pipeline Products By Therapy Area 57
Table 35: NeuroDerm Ltd.
Pipeline Products By Clinical Trials 57
Table 36: OcuPharma Ltd.
Pipeline Products by Equipment Type 58
Table 37: OcuPharma Ltd.
Pipeline Products by Development Stage 58
Table 38: OcuPharma Ltd.
Pipeline Products By Therapy Area 58
Table 39: ORADEL MEDICAL LTD.
Pipeline Products by Equipment Type 59
Table 40: ORADEL MEDICAL LTD.
Pipeline Products By Development Stage 59
Table 41: ORADEL MEDICAL
LTD. Pipeline Products By Therapy Area 59
Table 42: RescueDose L.T.D.
Pipeline Products by Equipment Type 60
Table 43: RescueDose L.T.D.
Pipeline Products by Development Stage 60
Table 44: RescueDose L.T.D.
Pipeline Products By Therapy Area 60
Table 45: SONENCO LTD. Pipeline
Products by Equipment Type 61
Table 46: SONENCO LTD. Pipeline
Products by Equipment Type 61
Table 47: SONENCO LTD. Pipeline
Products By Therapy Area 61
Table 48: SteadyMed Ltd. Pipeline
Products by Equipment Type 62
Table 49: SteadyMed Ltd. Pipeline
Products by Development Stage 62
Table 50: SteadyMed Ltd. Pipeline
Products By Therapy Area 62
Table 51: SteadyMed Ltd. Pipeline
Products By News Summaries 62
Table 52: Unique Flow Ltd. Pipeline
Products by Equipment Type 63
Table 53: Unique Flow Ltd. Pipeline
Products by Development Stage 63
Table 54: Unique Flow Ltd. Pipeline
Products By Therapy Area 63
Table 55: Currency Conversion from USD to
Local Currency at 2007 Constant Rate 68
1.2 List of Figures
Figure 1: Drug Delivery Devices Cross Country Comparison (2000-2012)
19
Figure 2: Drug Delivery Devices, Israel, Overall Revenues ($ mn),
2000-2012 20
Figure 3: Drug Delivery Devices, Israel, Portfolio Analysis,
2000-2012 21
Figure 4: Drug Delivery Devices, Israel, Overall
Revenues ($ mn), Historic, 2000-2007 22
Figure 5: Drug Delivery
Devices, Israel, Overall Revenues ($ mn), Forecast, 2007-2012 23
Figure 6:
Drug Delivery Devices, Israel, Category Volume (Units), 2000-2012 24
Figure 7: Drug Delivery Devices, Israel, Category Volume (Units),
Historic, 2000-2007 25
Figure 8: Drug Delivery Devices, Israel,
Category Volume (Units), Forecast, 2007-2012 26
Figure 9: Drug
Delivery Devices, Israel, Company Share (%), 2007 27
Figure 10:
Infusion Systems, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007
28
Figure 11: Infusion Systems, Israel, Revenue ($ mn) by Segment,
Forecast, 2007-2012 29
Figure 12: Infusion Systems, Israel, Company
Share (%), 2007 33
Figure 13: Inhalation Systems, Israel, Revenue ($
mn) by Segment, Historic, 2000-2007 34
Figure 14: Inhalation Systems,
Israel, Revenue ($ mn) by Segment, Forecast, 2007-2012 35
Figure 15:
Inhalation Systems, Israel, Overall Volume (Units), Historic, 2000-2007 36
Figure 16: Inhalation Systems, Israel, Overall Volume (Units), Forecast,
2007-2012 37
Figure 17: Inhalation Systems, Israel, Company Share
(%), 2007 39
Figure 18: 3M Healthcare Value Chain Analysis 42
Figure 19: Cardinal Health, Inc. Value Chain Analysis 47
Figure 20:
Baxter International Inc. Value Chain Analysis 50
Figure 21: Global
Markets Direct Methodology 64
|
Related Report
|
View Cart
